Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

Brand-Schieber E, Munjal S, Kumar R, Andre AD, Valladao W, Ramirez M.

Med Devices (Auckl). 2016 May 30;9:131-7. doi: 10.2147/MDER.S105899. eCollection 2016.

2.

Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.

Kleinschnitz C, Niemczyk G, Rehberg-Weber K, Wernsdörfer C.

Int J Mol Sci. 2015 Jul 6;16(7):15271-86. doi: 10.3390/ijms160715271.

3.

Pain sensitivity in posttraumatic stress disorder and other anxiety disorders: a preliminary case control study.

Mostoufi S, Godfrey KM, Ahumada SM, Hossain N, Song T, Wright LJ, Lohr JB, Afari N.

Ann Gen Psychiatry. 2014 Nov 18;13(1):31. doi: 10.1186/s12991-014-0031-1. eCollection 2014.

4.

A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate.

Masid ML, Ocaña RH, Gil MJ, Ramos MC, Roig ME, Carreño MR, Morales JC, Carrasco ML, Hidalgo LM, Felices AM, Castaño AH, Romero PC, Martinez PF, Sánchez-De la Rosa R.

J Neurosci Nurs. 2015 Feb;47(1):E22-30. doi: 10.1097/JNN.0000000000000086.

5.

Skin blood perfusion and cellular response to insertion of insulin pen needles with different diameters.

Præstmark KA, Jensen CB, Stallknecht B, Madsen NB, Kildegaard J.

J Diabetes Sci Technol. 2014 Jul;8(4):752-9. doi: 10.1177/1932296814531099. Epub 2014 Apr 17.

6.

Adherence to first-line disease-modifying therapy for multiple sclerosis in kuwait.

Alroughani R, Thussu A.

Int J MS Care. 2012 Spring;14(1):17-24. doi: 10.7224/1537-2073-14.1.17.

7.

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.

Boeru G, Milanov I, De Robertis F, Kozubski W, Lang M, Rojas-Farreras S, Tomlinson M.

Med Devices (Auckl). 2013 Nov 15;6:175-84. doi: 10.2147/MDER.S52590. eCollection 2013.

8.

Improving patient acceptance of insulin therapy by improving needle design.

Norman JJ, Prausnitz MR.

J Diabetes Sci Technol. 2012 Mar 1;6(2):336-8.

9.
10.

The role of comfort and discomfort in insulin therapy.

Aronson R.

Diabetes Technol Ther. 2012 Aug;14(8):741-7. doi: 10.1089/dia.2012.0038. Epub 2012 Apr 26. Review.

11.
12.

Injectability evaluation: an open issue.

Cilurzo F, Selmin F, Minghetti P, Adami M, Bertoni E, Lauria S, Montanari L.

AAPS PharmSciTech. 2011 Jun;12(2):604-9. doi: 10.1208/s12249-011-9625-y. Epub 2011 May 7.

13.

Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Wicks P, Massagli M, Kulkarni A, Dastani H.

J Med Internet Res. 2011 Jan 24;13(1):e12. doi: 10.2196/jmir.1687.

Items per page

Supplemental Content

Write to the Help Desk